longitudin survey apolipoprotein atherogen risk hemodialysi continu ambulatori periton dialysi patient total cholesterol TC hdl-cholesterol hdl-c dialysi patient systemat studi apolipoprotein apo a-i apo anti-atherogen risk ratio apo a-i/apo time lipid apo valu month hemodialysi HD continu ambulatori periton dialysi capd patient HD patient mean TC hdl-c tc/hdl-c atherogen risk ratio time apo a-i/apo month HD studi period t-test analysi race gender nondiabet apo a-i apo a-i/apo similar trend subgroup diabet capd patient total month treatment tc/hdl-c hdl-c analysi longitudin data signific chang TC hdl-c apo a-i apo tc/hdl-c a-i/apo lipoprotein pattern patient differ patient longitudin data reveal lipid apolipoprotein risk ratio stabl time HD capd fact anti-atherogen index apo a-i/apo HD patient nondiabet 